{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-018553","form_type":"8-K","ticker":"CLDI","cik":"0001855485","company_name":"Calidi Biotherapeutics, Inc.","filed_at":"2025-07-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.389962+00:00","generated_at":"2026-05-18T08:47:18.900900+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Calidi Biotherapeutics raises $4.6M via warrant exercise at $0.70/share","bullets":["Gross proceeds ~$4.6M from immediate exercise of 6,595,000 warrants at $0.70/share.","New Series H warrants issued for up to 6,595,000 shares at $0.70, exercisable after 6 months.","7 warrant holders participated; closing expected July 10, 2025.","Net proceeds for clinical programs and working capital.","Ladenburg Thalmann acts as placement agent with 8% fee."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-018553","json":"https://secwatch.observer/filing/0001641172-25-018553.json","markdown":"https://secwatch.observer/filing/0001641172-25-018553.md","text":"https://secwatch.observer/filing/0001641172-25-018553.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855485/000164117225018553/0001641172-25-018553-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855485/000164117225018553/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T08:47:18.900900+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}